ロード中...
Recent advances in the generation of human monoclonal antibody
The use of monoclonal antibodies (mAbs) has now gained a niche as an epochal breakthrough in medicine. Engineered antibodies (Abs) currently account for over 30% of biopharmaceuticals in clinical trials. Several methods to generate human mAbs have evolved, such as (1) immortalization of antigen-spec...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Netherlands
2007
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2104546/ https://ncbi.nlm.nih.gov/pubmed/19002994 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10616-007-9072-5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|